Alternative approaches to Hsp90 modulation for the treatment of cancer

Area of Science:

• Molecular Biology
• Biochemistry
• Oncology

Background:

• Heat shock protein 90 (Hsp90) is a molecular chaperone essential for the conformational maturation of client proteins and re-maturation of denatured proteins.
• Hsp90 functions through a chaperone cycle, requiring various co-chaperones and partner proteins for its activity.
• Inhibition of Hsp90 is a validated anticancer strategy due to the critical role of its client proteins in oncogenic pathways.

Purpose of the Study:

• To review current Hsp90 inhibitors and their mechanisms of action.
• To discuss the Hsp90 chaperone cycle and its regulation.
• To explore alternative strategies for inhibiting Hsp90 function beyond N-terminal inhibition.

Main Methods:

• Review of existing literature on Hsp90 inhibitors.
• Analysis of the Hsp90 chaperone cycle and regulatory mechanisms.
• Comparison of different Hsp90 inhibition strategies (N-terminal, C-terminal, co-chaperone disruption).

Main Results:

• Hsp90 N-terminal inhibition is a clinically relevant anticancer strategy.
• Alternative strategies, including C-terminal inhibition and co-chaperone disruption, also inhibit cancer cell proliferation.
• C-terminal inhibitors and co-chaperone disruptors destabilize client proteins without inducing heat shock proteins, unlike some N-terminal inhibitors.

Conclusions:

• Hsp90 inhibition represents a significant therapeutic avenue in oncology.
• Targeting different domains or co-chaperones of Hsp90 offers versatile strategies for cancer treatment.
• Understanding Hsp90 regulation and inhibition is key to developing effective anticancer therapies.